COVID-19 and IBD drugs: Should we change anything at the moment?

Charlie W. Lees^*, Peter M. Irving, Laurent Beaugerie

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › peer-review

14 Citations (Scopus)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{eae019abab8441cf8d75708250730681,

title = "COVID-19 and IBD drugs: Should we change anything at the moment?",

author = "Lees, {Charlie W.} and Irving, {Peter M.} and Laurent Beaugerie",

year = "2020",

doi = "10.1136/gutjnl-2020-323247",

language = "English",

journal = "Gut",

issn = "0017-5749",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - COVID-19 and IBD drugs

T2 - Should we change anything at the moment?

AU - Lees, Charlie W.

AU - Irving, Peter M.

AU - Beaugerie, Laurent

PY - 2020

Y1 - 2020

UR - http://www.scopus.com/inward/record.url?scp=85096799419&partnerID=8YFLogxK

U2 - 10.1136/gutjnl-2020-323247

DO - 10.1136/gutjnl-2020-323247

M3 - Comment/debate

C2 - 33214164

AN - SCOPUS:85096799419

SN - 0017-5749

JO - Gut

JF - Gut

ER -